Compugen Ltd. (CGEN)
|5.64 0.09 (1.62%) 11-15 16:002019-11-15|
|Exchange:||NASDAQ Global Market|
Compugen Ltd is a therapeutic discovery company. The Company's pipeline consists of early-stage immuno-oncology programs aimed at harnessing the immune system to fight cancer.
|Profit Margin (%)||0.00|
|Operating Margin (%)||-365.76|
|Return on Assets (ttm)||-35.9|
|Return on Equity (ttm)||-74.4|
Fri, 01 Nov 2019 10:28:12 +0000Healthcare Stocks That Hit New Highs ( REPH, CNMD, DRNA,...)
Mon, 05 Aug 2013 08:38:52 +0000Market Wrap For Monday, August 5: Stocks Close Mixed; Nasdaq Rises, Dow And S&P Fall Modestly
Fri, 08 Mar 2019 15:04:00 +0000Achillion (ACHN) Reports Narrower-Than-Expected Loss in Q4
Thu, 07 Mar 2019 14:06:00 +0000Merrimack (MACK) Incurs Narrower-Than-Expected Loss in Q4
Wed, 07 Nov 2018 15:50:00 +0000Bristol-Myers, Infinity to Test Opdivo Combo for Bladder Cancer
Tue, 06 Nov 2018 16:17:00 +0000What's in the Cards for Perrigo (PRGO) This Earnings Season?
©Foxchart.com All Rights Reserved. Foxchart.com | United States NYSE NASDAQ AMEX stock markets, stock quotes and stock technical analysis charts. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither Foxchart.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: IEX